Carrie McAdam-Marx

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi Effect of Medicare reimbursement reduction for imaging services on osteoporosis screening rates
    Carrie McAdam-Marx
    Pharmacotherapy and Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, Utah 84108, USA
    J Am Geriatr Soc 60:511-6. 2012
  2. ncbi All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective
    Carrie McAdam-Marx
    Pharmacotherapy Outcomes Research Center, University of Utah, 421 Wakara Way, Room 208, Salt Lake City, UT 84108, USA
    J Manag Care Pharm 17:531-46. 2011
  3. ncbi Costs of opioid abuse and misuse determined from a Medicaid database
    Carrie McAdam-Marx
    University of Utah, Salt Lake City, Utah, USA
    J Pain Palliat Care Pharmacother 24:5-18. 2010
  4. ncbi Physician utilization by insurance type among youth with type 2 diabetes
    Carrie McAdam-Marx
    Department of Pharmacotherapy, University of Utah, 421 Wakara Way, Rm 208, Salt Lake City, UT 84108, USA
    Am J Manag Care 16:55-64. 2010
  5. ncbi Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin
    Carrie McAdam-Marx
    University of Utah Department of Pharmacotherapy, Salt Lake City, Utah 84108, USA
    Curr Med Res Opin 26:191-201. 2010
  6. ncbi Analysis of glycaemic control and weight change in patients initiated with human or analog insulin in an US ambulatory care setting
    C McAdam-Marx
    University of Utah, Pharmacotherapy Outcomes Research Center, Salt Lake City, UT, USA
    Diabetes Obes Metab 12:54-64. 2010
  7. ncbi Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting
    Carrie McAdam-Marx
    Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, Utah 84108, USA
    Clin Ther 31:1116-23. 2009
  8. ncbi Systematic analysis of outcomes evaluations applied to drug management programs
    Carrie McAdam-Marx
    Department of Pharmacotherapy, University of Utah, 421 Wakara Wy, Rm 208, Salt Lake City, UT 84108, USA
    Am J Manag Care 14:SP36-45. 2008
  9. ncbi Cost and comorbidities associated with opioid abuse in managed care and Medicaid patients in the United Stated: a comparison of two recently published studies
    Sameer R Ghate
    Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, Utah 84108, USA
    J Pain Palliat Care Pharmacother 24:251-8. 2010
  10. ncbi Concurrent control of blood glucose, body mass, and blood pressure in patients with type 2 diabetes: an analysis of data from electronic medical records
    Carrie McAdam-Marx
    Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA
    Clin Ther 33:110-20. 2011

Detail Information

Publications21

  1. ncbi Effect of Medicare reimbursement reduction for imaging services on osteoporosis screening rates
    Carrie McAdam-Marx
    Pharmacotherapy and Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, Utah 84108, USA
    J Am Geriatr Soc 60:511-6. 2012
    ..8B over 5 years...
  2. ncbi All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective
    Carrie McAdam-Marx
    Pharmacotherapy Outcomes Research Center, University of Utah, 421 Wakara Way, Room 208, Salt Lake City, UT 84108, USA
    J Manag Care Pharm 17:531-46. 2011
    ..46 billion in 1997, and direct medical costs have been predicted to increase to $10.7 billion for the 10-year period from 2010 through 2019, due in part to the increasing number of HCV patients developing advanced liver disease (AdvLD)...
  3. ncbi Costs of opioid abuse and misuse determined from a Medicaid database
    Carrie McAdam-Marx
    University of Utah, Salt Lake City, Utah, USA
    J Pain Palliat Care Pharmacother 24:5-18. 2010
    ..Successful interventions to prevent opioid abuse and manage comorbidities could help to reduce costs associated with opioid abuse in the Medicaid population...
  4. ncbi Physician utilization by insurance type among youth with type 2 diabetes
    Carrie McAdam-Marx
    Department of Pharmacotherapy, University of Utah, 421 Wakara Way, Rm 208, Salt Lake City, UT 84108, USA
    Am J Manag Care 16:55-64. 2010
    ....
  5. ncbi Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin
    Carrie McAdam-Marx
    University of Utah Department of Pharmacotherapy, Salt Lake City, Utah 84108, USA
    Curr Med Res Opin 26:191-201. 2010
    ..The aim of this study was to compare the amount of insulin utilized in a large cohort of patients with type 2 diabetes treated with either DET or GLAR in the real-world setting considering the use of other antidiabetic agents...
  6. ncbi Analysis of glycaemic control and weight change in patients initiated with human or analog insulin in an US ambulatory care setting
    C McAdam-Marx
    University of Utah, Pharmacotherapy Outcomes Research Center, Salt Lake City, UT, USA
    Diabetes Obes Metab 12:54-64. 2010
    ..The likelihood of weight gain was less with insulin detemir than with insulin glargine. Thus, real-world weight outcomes for basal analog insulin may differ by specific product...
  7. ncbi Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting
    Carrie McAdam-Marx
    Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, Utah 84108, USA
    Clin Ther 31:1116-23. 2009
    ..Resistant hypertension, or failure to attain blood pressure (BP) goals while treated with > or = 3 antihypertensives (including a diuretic), occurred in 15% to 18% of patients in prospective cohort trials...
  8. ncbi Systematic analysis of outcomes evaluations applied to drug management programs
    Carrie McAdam-Marx
    Department of Pharmacotherapy, University of Utah, 421 Wakara Wy, Rm 208, Salt Lake City, UT 84108, USA
    Am J Manag Care 14:SP36-45. 2008
    ..To evaluate prior analyses that quantify how drug management programs impact health plans and patients with respect to those analyses' effectiveness in measuring program quality...
  9. ncbi Cost and comorbidities associated with opioid abuse in managed care and Medicaid patients in the United Stated: a comparison of two recently published studies
    Sameer R Ghate
    Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, Utah 84108, USA
    J Pain Palliat Care Pharmacother 24:251-8. 2010
    ..These studies confirm that opioid abuse is associated with comorbidities that increase direct medical costs for patients with private insurance and for Medicaid beneficiaries, increasing the societal burden of opioid abuse...
  10. ncbi Concurrent control of blood glucose, body mass, and blood pressure in patients with type 2 diabetes: an analysis of data from electronic medical records
    Carrie McAdam-Marx
    Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA
    Clin Ther 33:110-20. 2011
    ..This cross-sectional study describes glycemic, body mass, and blood pressure (BP) control in patients with type 2 diabetes mellitus (T2DM) in an ambulatory care-based database of electronic medical records (EMRs)...
  11. ncbi Clinical risk factors for fracture among postmenopausal patients at risk for fracture: a historical cohort study using electronic medical record data
    Joanne LaFleur
    Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA
    J Bone Miner Metab 29:193-200. 2011
    ..3%). Despite the limitations, the EMR data were useful for identifying women at highest risk for fracture. Some evidence of bias in reporting rates was present. EMR data can be useful for identifying high fracture risk patients...
  12. ncbi Assessment of time to follow-up visits in newly-treated hypertensive patients using an electronic medical record database
    Diana I Brixner
    University of Utah College of Pharmacy, Department of Pharmacotherapy, Salt Lake City, UT 84112, USA
    Curr Med Res Opin 26:1881-91. 2010
    ..Findings were compared to treatment guidelines which recommend monthly follow-up in treatment naive patients until blood pressure (BP) levels are controlled...
  13. ncbi Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record database
    Diana Brixner
    University of Utah College of Pharmacy, Department of Pharmacotherapy, 30 South 2000 East, Room 258, Salt Lake City, UT 84108, USA
    J Manag Care Pharm 14:756-67. 2008
    ....
  14. ncbi Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature
    Joanne LaFleur
    Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT 84108, USA
    Ann Pharmacother 42:375-86. 2008
    ....
  15. ncbi Evaluation of adverse events of oral antihyperglycemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysis
    Carl V Asche
    Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah 84108, USA
    Drugs Aging 25:611-22. 2008
    ..To evaluate and compare the risk of adverse events (AEs) associated with the use of metformin, sulfonylureas and thiazolidinediones among geriatric patients in a usual care setting...
  16. ncbi Patent extension policy for paediatric indications: an evaluation of the impact within three drug classes in a state Medicaid programme
    Richard E Nelson
    School of Medicine, University of Utah, Division of Epidemiology, Salt Lake City, Utah 84148, USA
    Appl Health Econ Health Policy 9:171-81. 2011
    ..Branded drugs in the statin, ACE inhibitor and selective serotonin reuptake inhibitor (SSRI) classes were three of many classes with drugs granted patent extensions...
  17. ncbi Problems in studying the association between race and pain in outcomes research
    Joanne LaFleur
    Pharmacotherapy Outcomes Research Center, 421 Wakara Way Rm 208, Salt Lake City, UT 84115, USA
    J Pain Palliat Care Pharmacother 21:57-62. 2007
    ....
  18. ncbi Cost-effectiveness of insulin analogs
    Diana I Brixner
    Outcomes Research Center, University of Utah, Salt Lake City, UT 84108, USA
    Am J Manag Care 14:766-75. 2008
    ..To examine the cost-effectiveness of analogs versus human insulins, citing primarily studies conducted in the United States...
  19. ncbi The societal costs of low back pain: data published between 2001 and 2007
    Carl V Asche
    Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, 421 Wakara Way, Suite 208, Salt Lake City, UT 84108, USA
    J Pain Palliat Care Pharmacother 21:25-33. 2007
    ..Newer, more costly agents such cyclooxengenase-2 selective nonsterioidal anti-inflammatory agents will increase drug costs as a portion of total costs, particularly if not used in accordance with treatment guidelines...
  20. ncbi Systematic review on quality control for drug management programs: is quality reported in the literature?
    Anke Peggy Holtorf
    Department of Pharmacotherapy, The University of Utah, Millcreek Outcomes Group, Salt Lake City, UT, USA
    BMC Health Serv Res 9:38. 2009
    ..The objective of this study was to evaluate how the impact of drug management programs is reported in the literature and to identify potentially existing quality standards...
  21. ncbi Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance
    Carl Asche
    Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, College of Pharmacy, University of Utah, 421 Wakara Way, Suite 208, Salt Lake City, UT 84108, USA
    J Antimicrob Chemother 61:1162-8. 2008
    ..The aim is to quantify community-acquired pneumonia (CAP) treatment outcomes and costs from a managed care perspective by the level of macrolide resistance corresponding to the metropolitan statistical area (MSA) where patients lived...